亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢楷倫化學新材料有限公司市場  

比馬前列素 阿瑞匹坦及中間體 亞硝基過***鉀 埃索美拉唑鈉及中間體 CB-03-1

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:江君
  • 電話:027-87773372
  • 郵件:2513471628@qq.com
  • QQ:2513471628
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 蘭索拉唑磺酰化物
蘭索拉唑磺?;?/strong>
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
過期 長期有效
更新 2019-06-28 09:55
 
詳細信息
 蘭索拉唑磺酰化物
中文名稱: 蘭索拉唑磺酸鹽 蘭索拉唑磺酸鹽
中文別名: 蘭索拉唑磺酸鹽 
英文名稱: 1H-Benzimidazole,2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]- 
英文別名: 2-[(3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methylsulfonyl]-1H-benzimidazole;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole;AG 1813; Lansoprazole sulfone 
CAS No.: 131926-99-3 
分 子 式: C16H14 F3 N3 O3 S 
分 子 量: 385.36 
熔 點: 207℃(dec.) 
分子結構式: 
產品名稱: 蘭索拉唑EP雜質B  
別名: 蘭索拉唑砜  
Cas No.: 131926-99-3  
含量: ≥98% 
 
©2025 武漢楷倫化學新材料有限公司市場 版權所有   技術支持:化工網   訪問量:10578  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |